Rickettsia prowazeki, pretreated with typhus immune human serum, readily infects, and grows in, chicken embryo cells in culture. This finding is similar to those of previous studies which showed that typhus rickettsiae, pretreated with immune serum, grow in cells of the yolk sac of embryonated hen eggs and in the cells of the midgut of the human body louse. In contrast, identically treated typhus rickettsiae were destroyed by human macrophages in culture. Collectively, these observations seem to support an emerging concept that the fate of antibody-sensitized typhus rickettsiae depends upon the presence or absence of certain specialized properties of the host cell into which they gain entrance-nonphagocytic cells or "nonprofessional" phagocytic cells versus certain kinds of "professional" phagocytes. The phenomena involved probably have an important bearing on the mechanisms of the persisting infection and the nonsterile immunity which characterizes convalescence from typhus fever in man. They also form the basis for certain practical technical innovations in the laboratory.
Studies on humoral immune mechanisms following typhus infections (1, 5, 6 ; C. L. Wisseman, Jr., D. W. Krause, I. B. Fabrikant, and P. A. Machowiak, J. Infect. Dis., submitted for publication) have revealed that human typhus immune serum (i) confers strong passive protection on animals against virulent challenge, (ii) exerts no direct rickettsiacidal action but strongly opsonizes Rickettsia prowazeki and R. mooseri (R. typhi) for phagocytosis by both polymorphonuclear leukocytes and the monocyte-macrophage series, and (iii) prepares typhus rickettsiae for retention and destruction within vacuoles of human macrophages, which otherwise are unable to restrict rickettsial growth. Thus, immune serum and macrophages, neither of which is sufficient alone to account for the remarkable protective action of immune serum passively transferred to the intact animal, appear to work in concert to destroy the typhus rickettsiae.
On the other hand, unrestricted growth of antibody-sensitized typhus rickettsiae occurs in the yolk sac cells of the embryonated hen egg, in the midgut cells of the human body louse, Pediculus humanus humanus L. (2) , and in the rare cell in cultures of macrophages derived from human peripheral monocytes (6) . This suggests that the intracellular fate of an antibody-sensitized rickettsia may depend upon the specific properties of the kind of cell into which it gains entrance, i.e., it is a host cell-determined phenomenon. However, the possibility exists that the yolk sac and louse gut cells represent very special cases in which extracellular enzymes might digest away or alter the immunoglobulins on the rickettsial surface, thus freeing it to penetrate the cells unimpeded. Therefore, to test the evolving hypothesis regarding the determining role of the host cell on the fate of antibody-sensitized rickettsiae, experiments were performed with cultures of cells not uniquely specialized for either phagocytic or digestive roles, i.e., chicken embryo fibroblasts (8 (Fig. 1) . On the basis of the detailed study of the growth cycle of R. prowazeki in irradiated CE cells (Wisseman, Waddell, and Walsh, manuscript in preparation), it has been established that the observations of the first 36 to 48 h were confined largely to a single infection cycle, which might be expected to reasonably reflect the influence of pretreatment on the interaction between the CE cells and the rickettsiae.
The rickettsiae appeared to behave within the CE cells in qualitatively the same manner regardless of the nature of the pretreatment of the rickettsiae, i.e., NHS, IHS, or MBSA. The differences which do appear are quantitative and are related to the enhanced entry into cells by pretreatment with IHS or MBSA, as reflected by the initial percentage of cells infected. Once within CE cells, however, the rickettsiae appeared to multiply at similar rates regardless of the kind of pretreatment (see average number of rickettsiae per infected cell). Thus, it is clear that irradiated CE cells do not have the capacity to destroy or restrict the intracellular growth of R. prowazeki which have been pretreated with typhus immune human serum or with MBSA; instead, entry of the rickettsiae into these cells and their arrival at an intracellular site conducive to multiplication are actually enhanced.
Effect of pretreatment of R. prowazeki with IHS or MBSA on the capacity of R. prowazeki to form plaques in CE cell monolayers. Preincubation of the rickettsiae with serum from a subject solidly immune to epidemic typhus did not interfere greatly with the capacity of the organisms to produce plaques on the CE cell monolayers; i.e., it exerted no dramatic '"neutralizing" action ( Table 1 ). The mean plaque count obtained when the results of all three replicates were combined was somewhat lower than that of the control, with a difference significant at the 5% level in the t test. However, the possibility that the immune serum caused some clumping of organisms cannot be excluded. In any case, plaque formation by antibody-sensitized rickettsiae in CE cell cultures was in fact remarkably efficient, results which lend support to the conclusions derived from the slide chamber experiments described above that these CE cells do not have the capacity to destroy or seriously limit multiplication of antibody-sensitized rickettsiae or, conversely, antibody did not interfere appreciably with the capacity of the rickettsiae to establish infection and produce plaques in CE cell cultures.
In contrast, pretreatment of the rickettsiae with MBSA increased the number of plaques (significant at the 0.1% level); however, the resulting enhancement of plaquing efficiency was not sufficient to reduce appreciably the discrepancy of about two orders of magnitude between the number of rickettsial bodies in the suspension and the plaque-forming units (2) . DISCUSSION This study has shown that R. prowazeki, previously incubated with IHS, infects CE cells in culture with an efficiency which even exceeds, under certain conditions, that of rickett-. _ % Cells Infected --j. mooseri (6) and R. prowazeki (L. Beaman and C. L. Wisseman, Jr., submitted for publication) are destroyed after ingestion. These observations suggest that the fate of antibody-sensitized typhus rickettsiae depends upon the kind of cell into which they gain entrance. It would appear that only certain kinds of cells, specialized as "professional phagocytes" (9) , may have the capacity to destroy antibody-sensitized rickettsiae. In the case of human macrophages in cell culture, it has been shown that antibody-sensitized R. mooseri are retained in phagocytic vacuoles where they are destroyed, whereas in the absence of antibody, the organisms rapidly escape from the vacuoles into the cytoplasm where they grow (1) .
One explanation for the difference in fate of antibody-sensitized rickettsiae in CE cells as compared with human macrophages might lie in differences in the mode of entry into the cell. We have growing evidence that typhus rickettsiae can enter the cytoplasm of cells by two different mechanisms: (i) direct penetration through the cell membrane into the cytoplasm, in a manner similar to that described by Cohn et al. (4) for R. tsutsugamushi (C. L. Wisseman, Jr., A. D. Waddell, and W. T. Walsh, manuscript in preparation) and (ii) phagocytosis followed by rapid escape from the phagocytic vacuole, as demonstrated with R. mooseri in human macrophages (1) . Antibody might be expected to interfere both with direct penetration in which uptake would be inhibited, or escape from phagocytic vacuoles, which might lead to intravacuolar destruction, as in the case of human macrophages, if the cell possessed appropriate lysosomal, enzymatic, or other antimicrobial apparatus (professional phagocytes).
Phagocytic activity by CE cells in culture has been reported to be very low (8) . In another study (C. L. Wisseman, Jr., A. D. Waddell, and W. T. Walsh, manuscript in preparation) on the kinetics of rickettsial uptake by CE cells and mechanisms of entry, evidence is presented that the usual mode of entry of non-antibody-sensitized R. prowazeki into these cells is most likely by direct penetration through the cell membrane into the cytoplasm. Therefore, the observed enhanced uptake of antibody-sensitized rickettsiae by CE cells in slide chamber cultures, but not in the plaque system, was unan- Regardless of the mechanisms involved, which also are considered in the separate study on uptake, the end result is that typhus immune serum does not interfere with the capacity of R. prowazeki to infect, grow in, and destroy CE cells in culture. Ongoing studies with mammalian cells of different origins suggest that this phenomenon is not unique to CE, yolk sac, or louse gut cells. Indeed, the capacity to destroy antibody-sensizited typhus rickettsiae may be limited to certain specialized cells, some professional phagocytes.
These findings, together with those previously reported for macrophages (5, 6) , have both theoretical and practical implications. On the one hand, they are consistent with our developing concepts about the mechanisms of nonsterile immunity and persisting infections in man and animals. On the other hand, they provide the basis for technical improvements in methods for detecting, isolating, and quantitating R. prowazeki from antibody-containing in vitro and in vivo systems as well as for detecting certain kinds of immune bodies simply by selecting a host cell with the appropriate characteristics.
